Natasha Bower, MD
Obstetrics & Gynecology · Fort Myers, FLNPI 1689892176
Payments from drug & device makers
Across 115 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$292
- Hologic Sales And Service, LLC$248
- Sumitomo Pharma America, Inc.$182
- Mayne Pharma Commercial LLC$173
- Pfizer$166
- Exeltis, USA Inc.$148
- plus $799 from 20 others
What the payments were for
- Food & beverage$1,95697%
- Education$523%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $292 |
| Hologic Sales And Service, LLC | 13 | $248 |
| Sumitomo Pharma America, Inc. | 10 | $182 |
| Mayne Pharma Commercial LLC | 13 | $173 |
| Pfizer | 9 | $166 |
| Exeltis, USA Inc. | 8 | $148 |
| Bayer | 7 | $127 |
| Astellas Pharma US Inc | 7 | $117 |
| Organon | 5 | $95 |
| Biogen | 3 | $62 |
| Merck | 3 | $49 |
| Therapeuticsmd, Inc. | 2 | $35 |
| Coopersurgical, Inc. | 2 | $35 |
| Covidien LP | 1 | $31 |
| Amgen | 2 | $31 |
| Evofem Biosciences, Inc. | 2 | $31 |
| Urovant Sciences Inc | 2 | $27 |
| Mycovia Pharmaceuticals, Inc. | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Medicem Inc. | 1 | $12 |
How this compares
$2,008 in reported general payments places this provider in the 65th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 74 | $3,902 |
| ValacyclovirValacyclovir Hcl | 16 | $1,061 |
| ProgesteroneProgesterone, Micronized | 12 | $333 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $221 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fort Myers
- Kevin FleishmanFort Myers$528K
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Guillermo LievanoMiami$2.5M
- Steven McCarusCelebration$2.3M
- Samuel WolfPanama City$2.1M
- Rafael Garcia-OcasioHialeah$2M
- Douglas MoffettLeesburg$1.7M
- Harvey GlasserAventura$1.6M
- Jorge PandoMiami Lakes$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.